Skip to main content
Group:
106 Articles Found

Telaprevir and Boceprevir: FDA Approval Soon

There is great excitement regarding the soon to be FDA approval of both Telaprevir and Boceprevir, in the treatment of chronic heaptitis C.   Read here for more information on Dr. Galati's opinion on what will be coming later this summer.


Liver Specialists of Texas Newsletter 14-Jan-11

Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, jobs and more from our membership.   Access To Your Medical Records SoonTo Be Available In the next several days, acces to your medical records will be available for those that are patients of our practice at Liver Specialists of Texas. Through eMDs, the electronic medical record that we use, a patient portal will be established. Before logging into the portal, you must first be issues a login and password. This can be done by first filling out this electronic release... [More Info]   Don't Eat At Olive Garden Dr. Joe Galati spoke about an experience at an Olive Garden Resturant recently on his radio program Your Health First several months ago.   Colon Cancer Interview With Dr. Joe Galati This is an archived radio interview and podcast …


Access To Your Medical Records SoonTo Be Available

                                        In the next several days, acces to your medical records will be available for those that are patients of our practice at Liver Specialists of Texas. Through eMDs, the electronic medical record that we use, a "patient portal" will be established.   Before logging into the portal, you must first be issues a login and password. This can be done by first filling out this electronic release form that our office must process. It only takes a few minutes, but is the first step to accessing your files. The release form can be downloaded here.   The Patient Portal is a web-based system that serves as a secure communication link between you and the clinic. When you log in to …


Don't Eat At Olive Garden

Dr. Joe Galati spoke about an experience at an Olive Garden Resturant recently on his radio program Your Health First several months ago.


Colon Cancer Interview With Dr. Joe Galati

This is an archived radio interview and podcast Dr. Galati performed a few years ago during an episode of "Your Health First", his weekly radio program on Clear Channel's 740 KTRH. He was discussing colon cancer with two patients who have an interesting story to tell regarding colon cancer.   The podcast can be listed to by going to the podcast page, where you will see all of the podcast episodes.


Liver Specialists of Texas Newsletter 24-Dec-10

Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, and more from our membership. December 2010   Dear Friends, Colleagues, and Patients of Liver Specialists of Texas:   I hope this message finds each and every one of you in good health, as we celebrate Christmas and the Holiday Season, with optimistic hopes for the New Year.   2010 has been an exciting year for our staff and patients. Earlier this fall, we had the addition of Dr. Saira Khaderi to our practice, a well trained and knowledgeable physician, committed to the care of our patients with liver disease. We also had the opportunity to enroll a large number of patients in various hepatitis C research studies, providing them the highest chances of eradicating this dreadful infection. For those with more advanced complications of liver disease, our liver transplant …


Liver Specialists of Texas Newsletter Volume 9 No 5

  Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, jobs and more from our membership. Keep up to date with the latest in liver disease news, as well as general health and wellness information. We all look forward to feed back, and topics in the future you would like to learn about.   March was Colon Cancer Awareness Month: Podcast   March was colon cancer awareness month. Listen to Dr. Galati's podcast here. Among cancers that affect both men and women, colorectal cancer—cancer of the colon or rectum—is the second leading cause of cancer-related deaths in the United States. Colorectal cancer also is one of the most commonly diagnosed cancers in the United States. The risk of developing colorectal cancer increases with advancing age. More than 90% of cases occur in people aged 50 or older. Colorectal cancer... …


March is Colon Cancer Awareness Month: Podcast

March is colon cancer awareness month. Listen to Dr. Galati's podcast here. Among cancers that affect both men and women, colorectal cancer—cancer of the colon or rectum—is the second leading cause of cancer-related deaths in the United States. Colorectal cancer also is one of the most commonly diagnosed cancers in the United States. The risk of developing colorectal cancer increases with advancing age. More than 90% of cases occur in people aged 50 or older. Colorectal cancer screening saves lives. However, many people who are at risk for the disease are not being screened according to national guidelines. It is estimated that as many as 60% of colorectal cancer deaths could be prevented if all men and women aged 50 years or older were screened routinely. In most cases, colorectal cancer develops from precancerous polyps in the colon or rectum. …


Mice Helping Unlock Hepatitis B and Hepatitis C Treatments

In my blog this week, I highlighted a recent study looking at the use of mice livers, manipulated to look like human liver, that would allow researchers to use this mice to test new drugs agains the hepatitis B and Hepatitis C virus.   The full blog report is posted here. The full articles are also available for those wanting more detail.   Enjoy.   Dr. Joseph S. Galati


Obesity and Fatty Liver Disease

Obesity, and all of its related complications, is more serious than most adults in America believe. More than one-third (34.9% or 78.6 million) of U.S. adults are obese. Obesity-related conditions include heart disease, stroke, type 2 diabetes, fatty liver disease, and certain types of cancer, are some of the leading causes of preventable death. We are seeing an increase in the number of young children and adolescents developing obesity, and all of the related complications.

The cost of obesity is staggering, with annual medical cost of obesity exceeding $147 billion in 2008 U.S. dollars. The medical costs for people who are obese were $1,429 higher than those of normal weight.

Dr. Galati and the Liver Specialists of Texas team are dedicated to evaluate, treat, and manage all aspects of obesity and non-alcoholic fatty liver disease (NAFLD and NASH), including the complication of cirrhosis and liver failure. Developing a customized plan of care for each patient they see is their objective.

Liver Transplant Resources

Dr. Galati has been involved in Liver Transplantation since 1989. As Medical Director for the Center for Liver Disease and Transplantation at Houston Methodist Hospital, Dr. Galati has cared for thousands of patients with advanced liver disease. In those with the most severe form of advanced liver disease and cirrhosis, liver transplantation is a life-saving surgery. For more information on liver transplantation, click here.

Indications for liver transplant include:

Online LIVER Second Opinion

  • 1

    From the comfort of your home, without the need to spend additional money on travel, lodging, and food, receive and expert second opinion from the expert physicians at Liver Specialists of Texas

  • 2

    There are five steps in the process of requesting a second opinion. We anticipate the steps will take you about 30-65 minutes to complete.

  • 3

    Have your medical records or those of your loved one on hand as you fill out the medical history questionnaire portion of the online process. The medical history questionnaire is detailed so having medical records to quickly reference will help make the process more efficient.

  • 4

    To start the process of an Online Liver Second Opinion, please fill out the initial contact form and fax back to our office. A representative from our office will call you for additional details.